10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VERA (Vera Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vera Therapeutics Inc together

I guess you are interested in Vera Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Vera Therapeutics Incโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Vera Therapeutics Incโ€™s Price Targets

I'm going to help you getting a better view of Vera Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Vera Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Vera Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$8.39
Expected worth in 1 year
$11.23
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
$2.85
Return On Investment
12.4%

For what price can you sell your share?

Current Price per Share
$23.00
Expected price per share
$18.53 - $33.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vera Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$23.00
Intrinsic Value Per Share
$-47.69 - $-56.62
Total Value Per Share
$-39.30 - $-48.23

2.2. Growth of Vera Therapeutics Inc (5 min.)




Is Vera Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$534.9m$179.8m$252.4m58.4%

How much money is Vera Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$43.8m-$23.5m-$20.2m-46.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Vera Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#117 / 884

Most Revenue
#834 / 884

Most Profit
#770 / 884

Most Efficient
#299 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vera Therapeutics Inc?

Welcome investor! Vera Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Vera Therapeutics Inc.

First you should know what it really means to hold a share of Vera Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Vera Therapeutics Inc is $23.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vera Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vera Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.39. Based on the TTM, the Book Value Change Per Share is $0.71 per quarter. Based on the YOY, the Book Value Change Per Share is $0.77 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vera Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.81-3.5%-0.69-3.0%-0.37-1.6%-0.17-0.8%-0.20-0.9%-0.20-0.9%
Usd Book Value Change Per Share-0.66-2.9%0.713.1%0.773.3%0.522.3%0.472.0%0.472.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.66-2.9%0.713.1%0.773.3%0.522.3%0.472.0%0.472.0%
Usd Price Per Share24.02-36.67-22.07-24.75-20.99-20.99-
Price to Earnings Ratio-7.41--13.79--14.34--11.22--14.61--14.61-
Price-to-Total Gains Ratio-36.34--47.37--36.29--43.72--48.12--48.12-
Price to Book Ratio2.86-6.08-7.94-7.94-8.50-8.50-
Price-to-Total Gains Ratio-36.34--47.37--36.29--43.72--48.12--48.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share23
Number of shares43
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.710.47
Usd Total Gains Per Share0.710.47
Gains per Quarter (43 shares)30.5920.04
Gains per Year (43 shares)122.3580.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1012211208070
202452340160150
303673560240230
404894780321310
506126000401390
607347220481470
708568440561550
809799660641630
90110110880721710
100122312100802790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.016.00.011.1%2.016.00.011.1%2.016.00.011.1%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vera Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.6610.711-193%0.768-186%0.523-226%0.466-242%0.466-242%
Book Value Per Share--8.3896.778+24%2.820+197%3.803+121%2.709+210%2.709+210%
Current Ratio--27.68222.064+25%12.386+123%13.958+98%15.002+85%15.002+85%
Debt To Asset Ratio--0.1230.158-22%0.288-57%0.236-48%0.486-75%0.486-75%
Debt To Equity Ratio--0.1410.191-26%0.430-67%0.332-58%0.253-44%0.253-44%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--2046522284.0002755200349.500-26%1571952473.000+30%1805277243.000+13%1698131172.500+21%1698131172.500+21%
Eps---0.811-0.688-15%-0.370-54%-0.175-78%-0.198-76%-0.198-76%
Ev To Ebitda Ratio---8.946-16.627+86%-16.049+79%-14.728+65%-20.938+134%-20.938+134%
Free Cash Flow Per Share---0.856-0.710-17%-0.391-54%-0.478-44%-0.371-57%-0.371-57%
Free Cash Flow To Equity Per Share---0.8320.590-241%0.793-205%0.519-260%0.523-259%0.523-259%
Gross Profit Margin--1.0001.0000%1.010-1%1.0030%1.0020%1.0020%
Intrinsic Value_10Y_max---56.616----------
Intrinsic Value_10Y_min---47.685----------
Intrinsic Value_1Y_max---2.460----------
Intrinsic Value_1Y_min---2.415----------
Intrinsic Value_3Y_max---9.841----------
Intrinsic Value_3Y_min---9.346----------
Intrinsic Value_5Y_max---20.174----------
Intrinsic Value_5Y_min---18.514----------
Market Cap1466806600.000-4%1531856284.0002338759349.500-35%1407177723.000+9%1578305159.667-3%1338549597.778+14%1338549597.778+14%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio2.742-4%2.8636.081-53%7.944-64%7.940-64%8.502-66%8.502-66%
Pe Ratio-7.094+4%-7.408-13.790+86%-14.336+94%-11.221+51%-14.614+97%-14.614+97%
Price Per Share23.000-4%24.02036.673-35%22.065+9%24.748-3%20.989+14%20.989+14%
Price To Free Cash Flow Ratio-6.717+4%-7.015-14.647+109%-13.491+92%-13.470+92%-19.303+175%-19.303+175%
Price To Total Gains Ratio-34.795+4%-36.338-47.370+30%-36.2940%-43.719+20%-48.120+32%-48.120+32%
Quick Ratio--51.36541.153+25%21.836+135%24.579+109%22.010+133%22.010+133%
Return On Assets---0.085-0.091+7%-0.108+27%-0.122+44%-0.154+81%-0.154+81%
Return On Equity---0.097-0.109+13%-0.160+65%-0.170+76%-0.141+46%-0.141+46%
Total Gains Per Share---0.6610.711-193%0.768-186%0.523-226%0.466-242%0.466-242%
Usd Book Value--534999000.000432270250.000+24%179864250.000+197%242531416.667+121%172742333.333+210%172742333.333+210%
Usd Book Value Change Per Share---0.6610.711-193%0.768-186%0.523-226%0.466-242%0.466-242%
Usd Book Value Per Share--8.3896.778+24%2.820+197%3.803+121%2.709+210%2.709+210%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--2046522284.0002755200349.500-26%1571952473.000+30%1805277243.000+13%1698131172.500+21%1698131172.500+21%
Usd Eps---0.811-0.688-15%-0.370-54%-0.175-78%-0.198-76%-0.198-76%
Usd Free Cash Flow---54593000.000-45299000.000-17%-24945500.000-54%-30494583.333-44%-23668000.000-57%-23668000.000-57%
Usd Free Cash Flow Per Share---0.856-0.710-17%-0.391-54%-0.478-44%-0.371-57%-0.371-57%
Usd Free Cash Flow To Equity Per Share---0.8320.590-241%0.793-205%0.519-260%0.523-259%0.523-259%
Usd Market Cap1466806600.000-4%1531856284.0002338759349.500-35%1407177723.000+9%1578305159.667-3%1338549597.778+14%1338549597.778+14%
Usd Price Per Share23.000-4%24.02036.673-35%22.065+9%24.748-3%20.989+14%20.989+14%
Usd Profit---51694000.000-43864750.000-15%-23576000.000-54%-30910250.000-40%-25753111.111-50%-25753111.111-50%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.6610.711-193%0.768-186%0.523-226%0.466-242%0.466-242%
 EOD+3 -5MRQTTM+13 -19YOY+16 -173Y+15 -185Y+17 -1610Y+17 -16

3.3 Fundamental Score

Let's check the fundamental score of Vera Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.094
Price to Book Ratio (EOD)Between0-12.742
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than151.365
Current Ratio (MRQ)Greater than127.682
Debt to Asset Ratio (MRQ)Less than10.123
Debt to Equity Ratio (MRQ)Less than10.141
Return on Equity (MRQ)Greater than0.15-0.097
Return on Assets (MRQ)Greater than0.05-0.085
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.590
Ma 20Greater thanMa 5023.661
Ma 50Greater thanMa 10022.736
Ma 100Greater thanMa 20024.950
OpenGreater thanClose23.500
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Fundamental data was last updated by Penke on 2025-06-20 18:44:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Vera Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • A Net Profit Margin of 0.0%ย means thatย $0.00 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--90.3%+90.3%
TTM--141.5%+141.5%
YOY--185.9%+185.9%
3Y--248.0%+248.0%
5Y--344.1%+344.1%
10Y--489.2%+489.2%
4.3.1.2. Return on Assets

Shows howย efficientย Vera Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • -8.5% Return on Assets means thatย Vera Therapeutics Inc generatedย $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vera Therapeutics Inc:

  • The MRQ is -8.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.5%TTM-9.1%+0.6%
TTM-9.1%YOY-10.8%+1.7%
TTM-9.1%5Y-15.4%+6.3%
5Y-15.4%10Y-15.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.5%-11.5%+3.0%
TTM-9.1%-11.6%+2.5%
YOY-10.8%-11.4%+0.6%
3Y-12.2%-11.9%-0.3%
5Y-15.4%-12.2%-3.2%
10Y-15.4%-13.9%-1.5%
4.3.1.3. Return on Equity

Shows how efficient Vera Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • -9.7% Return on Equity means Vera Therapeutics Inc generated $-0.10ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vera Therapeutics Inc:

  • The MRQ is -9.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-10.9%+1.2%
TTM-10.9%YOY-16.0%+5.1%
TTM-10.9%5Y-14.1%+3.2%
5Y-14.1%10Y-14.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-13.5%+3.8%
TTM-10.9%-15.0%+4.1%
YOY-16.0%-14.4%-1.6%
3Y-17.0%-17.0%+0.0%
5Y-14.1%-18.0%+3.9%
10Y-14.1%-20.4%+6.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vera Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Vera Therapeutics Inc is operatingย .

  • Measures how much profit Vera Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • An Operating Margin of 0.0%ย means the company generated $0.00 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vera Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.5%+229.5%
TTM--258.2%+258.2%
YOY--204.2%+204.2%
3Y--221.0%+221.0%
5Y--344.1%+344.1%
10Y--476.7%+476.7%
4.3.2.2. Operating Ratio

Measures how efficient Vera Therapeutics Inc is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.110-2.110
TTM-2.711-2.711
YOY-3.043-3.043
3Y-3.562-3.562
5Y-4.755-4.755
10Y-6.520-6.520
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vera Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Biotechnology industry mean).
  • A Current Ratio of 27.68ย means the company has $27.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 27.682. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.064. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ27.682TTM22.064+5.618
TTM22.064YOY12.386+9.678
TTM22.0645Y15.002+7.062
5Y15.00210Y15.0020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.6823.662+24.020
TTM22.0643.745+18.319
YOY12.3864.104+8.282
3Y13.9584.649+9.309
5Y15.0025.734+9.268
10Y15.0026.143+8.859
4.4.3.2. Quick Ratio

Measures if Vera Therapeutics Inc is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • A Quick Ratio of 51.36ย means the company can pay off $51.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 51.365. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 41.153. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ51.365TTM41.153+10.212
TTM41.153YOY21.836+19.317
TTM41.1535Y22.010+19.143
5Y22.01010Y22.0100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ51.3652.826+48.539
TTM41.1533.104+38.049
YOY21.8363.778+18.058
3Y24.5794.288+20.291
5Y22.0105.682+16.328
10Y22.0106.360+15.650
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vera Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Vera Therapeutics Incย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Vera Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12ย means that Vera Therapeutics Inc assets areย financed with 12.3% credit (debt) and the remaining percentage (100% - 12.3%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.123. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.158. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.123TTM0.158-0.035
TTM0.158YOY0.288-0.130
TTM0.1585Y0.486-0.327
5Y0.48610Y0.4860.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1230.324-0.201
TTM0.1580.349-0.191
YOY0.2880.329-0.041
3Y0.2360.339-0.103
5Y0.4860.349+0.137
10Y0.4860.384+0.102
4.5.4.2. Debt to Equity Ratio

Measures ifย Vera Therapeutics Inc is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • A Debt to Equity ratio of 14.1% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vera Therapeutics Inc:

  • The MRQ is 0.141. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.191. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.141TTM0.191-0.050
TTM0.191YOY0.430-0.239
TTM0.1915Y0.253-0.062
5Y0.25310Y0.2530.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1410.384-0.243
TTM0.1910.435-0.244
YOY0.4300.408+0.022
3Y0.3320.446-0.114
5Y0.2530.460-0.207
10Y0.2530.510-0.257
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Vera Therapeutics Inc generates.

  • Above 15 is considered overpriced butย always compareย Vera Therapeutics Inc to theย Biotechnology industry mean.
  • A PE ratio of -7.41 means the investor is paying $-7.41ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vera Therapeutics Inc:

  • The EOD is -7.094. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.408. Based on the earnings, the company is expensive. -2
  • The TTM is -13.790. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.094MRQ-7.408+0.315
MRQ-7.408TTM-13.790+6.382
TTM-13.790YOY-14.336+0.546
TTM-13.7905Y-14.614+0.824
5Y-14.61410Y-14.6140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.094-2.150-4.944
MRQ-7.408-2.004-5.404
TTM-13.790-2.524-11.266
YOY-14.336-3.716-10.620
3Y-11.221-3.703-7.518
5Y-14.614-6.057-8.557
10Y-14.614-6.653-7.961
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vera Therapeutics Inc:

  • The EOD is -6.717. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.015. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.647. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.717MRQ-7.015+0.298
MRQ-7.015TTM-14.647+7.632
TTM-14.647YOY-13.491-1.156
TTM-14.6475Y-19.303+4.656
5Y-19.30310Y-19.3030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.717-3.030-3.687
MRQ-7.015-2.710-4.305
TTM-14.647-3.643-11.004
YOY-13.491-4.385-9.106
3Y-13.470-5.050-8.420
5Y-19.303-8.550-10.753
10Y-19.303-9.339-9.964
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Vera Therapeutics Inc is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Biotechnology industry mean).
  • A PB ratio of 2.86 means the investor is paying $2.86ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vera Therapeutics Inc:

  • The EOD is 2.742. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.863. Based on the equity, the company is underpriced. +1
  • The TTM is 6.081. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD2.742MRQ2.863-0.122
MRQ2.863TTM6.081-3.218
TTM6.081YOY7.944-1.863
TTM6.0815Y8.502-2.421
5Y8.50210Y8.5020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7421.883+0.859
MRQ2.8631.855+1.008
TTM6.0812.119+3.962
YOY7.9442.469+5.475
3Y7.9402.504+5.436
5Y8.5023.657+4.845
10Y8.5024.297+4.205
4.6.2. Total Gains per Share

2.4. Latest News of Vera Therapeutics Inc

Does Vera Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Vera Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-26
02:15
Insider Purchase: Director at $VERA Buys 139,595 SharesRead
2025-06-26
02:10
Vera Therapeutics director Enright buys shares worth $5.2mRead
2025-06-09
22:05
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Read
2025-06-06
17:02
Biotech Stock Vera Is Slumping After Monster GainRead
2025-06-04
22:05
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare ConferenceRead
2025-06-02
21:27
Notable Monday Option Activity: VERA, REPL, CLFRead
2025-06-02
19:07
Vera rises after success in late-stage trial for IgA nephropathy treatmentRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vera Therapeutics Inc.

4.8.1. Institutions holding Vera Therapeutics Inc

Institutions are holding 112.409% of the shares of Vera Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31venBio Select Advisor LLC8.94082.13785701900919001.6381
2025-03-31T. Rowe Price Associates, Inc.7.45570.014147548323777838.631
2025-03-31BlackRock Inc6.26040.0023992537510511.2952
2025-03-31FMR Inc5.06840.00532323191791935.8692
2025-03-31Vanguard Group Inc4.57620.00132918423-31141-1.0558
2025-03-31Sofinnova Ventures4.38114.3831279398700
2025-03-31COMMODORE CAPITAL LP4.0174.5343256178260318230.7966
2025-03-31Vestal Point Capital LP3.92014.288325000001425000132.5581
2025-03-31Kynam Capital Management, LP3.76334.8432240000094209064.6192
2025-03-31Holocene Advisors, LP3.44860.1541219929232332917.2354
2025-03-31State Street Corp3.26630.00212083048566962.7979
2025-03-31Eversept Partners, LLC2.97744.632189880429878918.6741
2025-03-31T. Rowe Price Investment Management,Inc.2.6270.0266167536726018818.3855
2025-03-31Geode Capital Management, LLC1.8860.00231202809494844.2906
2025-03-31First Light Asset Management, LLC1.84383.22531175879-85367-6.7685
2025-03-31Integral Health Asset Management, LLC1.80322.9391115000000
2025-03-31Deerfield Management Co1.64640.498105000010500000
2025-03-31Woodline Partners LP1.56940.15631000849-201617-16.767
2025-03-31Samlyn Capital, LLC1.53420.3481978423-683797-41.1376
2025-03-31Deutsche Bank AG1.40.00858928598248310.1784
Total 72.385332.201546163110+4789246+10.4%

4.9.2. Funds holding Vera Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31T. Rowe Price New Horizons2.63140.25031678160-22694-1.3343
2025-03-31US Small-Cap Growth II Equity Comp2.63140.250316781601048356.6633
2025-04-30Vanguard Total Stock Mkt Idx Inv2.40930.00211536521352002.3446
2025-03-31T. Rowe Price Health Sciences1.9210.23871225097229891.9124
2025-04-30Fidelity Growth Compy Commingled Pl S1.86190.0348118742700
2025-05-31iShares Russell 2000 ETF1.78770.0351114009300
2025-05-31SPDRยฎ S&P Biotech ETF1.53140.394497662757820.5956
2025-04-30Fidelity Growth Company Fund1.38310.03588204400
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.35370.019886328511560.1341
2025-04-30Xtrackers S&P 500 Swap ETF 1C0.96910.149261804700
2025-03-31T. Rowe Price US Small-Cap Core Equity0.96260.190361388410705521.1225
2025-03-31T. Rowe Price Small-Cap Stock0.96260.1903613884-133-0.0217
2025-03-31T. Rowe Price Integrated US SmCapGrEq0.81640.1661520681-469281-47.4039
2025-03-31T. Rowe Price Integrated US Sm Gr Eq0.81640.166152068100
2025-03-31T. Rowe Price New Horizons Tr-A0.77860.264349655210181625.7934
2025-03-31Fidelity Small Cap Index0.71050.045453136127762.9013
2025-03-31Federated Hermes Kaufmann R0.6920.2451441300-183700-29.392
2025-03-31Federated Hermes Kaufmann Growth0.6920.245441300-183700-29.392
2025-02-28Pictet-Biotech P USD0.68831.0092438989-17177-3.7655
2025-05-31iShares Russell 2000 Growth ETF0.61380.067139142200
Total 26.21323.998216717290-485076-2.9%

5.3. Insider Transactions

Insiders are holding 5.155% of the shares of Vera Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-08Marshall FordyceSELL1750041.74
2024-12-18Marshall FordyceSELL1750043.07
2024-12-11Marshall FordyceSELL1750046.94
2024-10-28Beth C SeidenbergSELL1500048.03
2024-10-23Marshall FordyceSELL1937540.39
2024-10-09Marshall FordyceSELL1562538.24
2024-09-25Marshall FordyceSELL2312546.05
2024-09-18Beth C SeidenbergSELL117742.01
2024-09-11Marshall FordyceSELL1562537.5
2024-08-21Marshall FordyceSELL1447139.76
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets610,167
Total Liabilities75,168
Total Stockholder Equity534,999
 As reported
Total Liabilities 75,168
Total Stockholder Equity+ 534,999
Total Assets = 610,167

Assets

Total Assets610,167
Total Current Assets606,076
Long-term Assets4,091
Total Current Assets
Cash And Cash Equivalents 55,090
Short-term Investments 534,744
Other Current Assets 16,242
Total Current Assets  (as reported)606,076
Total Current Assets  (calculated)606,076
+/-0
Long-term Assets
Property Plant Equipment 3,977
Long-term Assets Other 114
Long-term Assets  (as reported)4,091
Long-term Assets  (calculated)4,091
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities21,894
Long-term Liabilities53,274
Total Stockholder Equity534,999
Total Current Liabilities
Short-term Debt 1,191
Accounts payable 9,262
Other Current Liabilities 2,179
Total Current Liabilities  (as reported)21,894
Total Current Liabilities  (calculated)12,632
+/- 9,262
Long-term Liabilities
Long term Debt 50,908
Capital Lease Obligations Min Short Term Debt2,366
Long-term Liabilities  (as reported)53,274
Long-term Liabilities  (calculated)53,274
+/-0
Total Stockholder Equity
Common Stock64
Retained Earnings -512,944
Accumulated Other Comprehensive Income 654
Other Stockholders Equity 1,047,225
Total Stockholder Equity (as reported)534,999
Total Stockholder Equity (calculated)534,999
+/-0
Other
Capital Stock64
Cash and Short Term Investments 589,834
Common Stock Shares Outstanding 63,672
Liabilities and Stockholders Equity 610,167
Net Debt -625
Net Invested Capital 585,907
Net Working Capital 584,182
Property Plant and Equipment Gross 3,977
Short Long Term Debt Total 54,465



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
54,554
51,825
97,647
91,167
83,748
164,974
148,782
131,370
131,435
209,604
195,178
175,618
175,546
419,356
397,291
368,560
655,681
610,167
610,167655,681368,560397,291419,356175,546175,618195,178209,604131,435131,370148,782164,97483,74891,16797,64751,82554,554000
   > Total Current Assets 
3,229
0
0
54,261
51,532
95,876
89,760
82,537
157,743
142,338
124,982
125,698
204,449
190,614
171,620
165,543
407,923
389,503
364,131
651,218
606,076
606,076651,218364,131389,503407,923165,543171,620190,614204,449125,698124,982142,338157,74382,53789,76095,87651,53254,261003,229
       Cash And Cash Equivalents 
-3,229
0
0
53,654
49,505
91,625
86,191
79,674
111,506
50,427
30,475
43,459
137,385
33,889
27,441
45,681
69,105
25,085
27,256
92,646
55,090
55,09092,64627,25625,08569,10545,68127,44133,889137,38543,45930,47550,427111,50679,67486,19191,62549,50553,65400-3,229
       Short-term Investments 
6,458
0
0
86
67
85
57
867
39,432
81,501
83,945
71,194
59,768
147,132
132,498
115,035
334,559
359,302
326,053
548,206
534,744
534,744548,206326,053359,302334,559115,035132,498147,13259,76871,19483,94581,50139,43286757856786006,458
       Net Receivables 
0
0
0
52
0
0
0
0
0
0
0
0
0
0
0
0
1,631
1,960
1,997
3,773
0
03,7731,9971,9601,63100000000000052000
       Other Current Assets 
0
0
0
607
2,027
4,251
3,569
2,863
6,805
10,410
10,562
11,045
7,296
9,593
11,681
11,307
11,075
8,400
10,822
6,593
16,242
16,2426,59310,8228,40011,07511,30711,6819,5937,29611,04510,56210,4106,8052,8633,5694,2512,027607000
   > Long-term Assets 
-3,229
0
0
293
293
1,771
1,407
1,211
7,231
6,444
6,388
5,737
5,155
4,564
3,998
10,003
11,433
7,788
4,429
4,463
4,091
4,0914,4634,4297,78811,43310,0033,9984,5645,1555,7376,3886,4447,2311,2111,4071,77129329300-3,229
       Property Plant Equipment 
0
0
0
0
0
0
0
0
6,291
5,745
5,824
5,224
4,594
4,070
3,481
3,041
2,513
2,084
4,289
4,332
3,977
3,9774,3324,2892,0842,5133,0413,4814,0704,5945,2245,8245,7456,29100000000
       Long Term Investments 
0
0
0
0
0
1,478
1,114
867
580
324
122
58
57
29
13
0
0
0
0
0
0
000000132957581223245808671,1141,47800000
       Long-term Assets Other 
-3,229
0
0
293
293
293
293
344
360
375
442
455
504
465
504
6,951
8,920
5,704
140
131
114
1141311405,7048,9206,95150446550445544237536034429329329329300-3,229
> Total Liabilities 
0
0
0
143,902
145,141
5,492
5,690
14,156
30,549
27,278
25,652
54,527
51,895
54,655
51,911
73,861
65,814
69,422
79,502
78,526
75,168
75,16878,52679,50269,42265,81473,86151,91154,65551,89554,52725,65227,27830,54914,1565,6905,492145,141143,902000
   > Total Current Liabilities 
0
0
0
2,406
3,753
3,771
4,042
7,690
19,969
17,279
15,920
25,600
23,529
26,835
24,621
22,303
14,543
18,418
26,464
25,371
21,894
21,89425,37126,46418,41814,54322,30324,62126,83523,52925,60015,92017,27919,9697,6904,0423,7713,7532,406000
       Short-term Debt 
0
0
0
2
0
0
0
0
4,980
4,900
5,378
2,645
5,204
5,120
5,036
4,872
2,275
4,232
1,872
1,483
1,191
1,1911,4831,8724,2322,2754,8725,0365,1205,2042,6455,3784,9004,98000002000
       Accounts payable 
0
0
0
909
1,440
1,723
964
1,385
7,328
7,084
7,012
11,991
5,326
13,280
12,300
11,118
5,209
4,664
4,602
7,665
9,262
9,2627,6654,6024,6645,20911,11812,30013,2805,32611,9917,0127,0847,3281,3859641,7231,440909000
       Other Current Liabilities 
0
0
0
1,495
2,313
2,048
3,078
6,305
7,661
5,295
3,530
10,964
12,999
8,435
7,285
6,313
7,059
9,522
19,990
16,223
2,179
2,17916,22319,9909,5227,0596,3137,2858,43512,99910,9643,5305,2957,6616,3053,0782,0482,3131,495000
   > Long-term Liabilities 
0
0
0
141,496
141,388
1,721
1,648
6,466
10,580
9,999
9,732
28,927
28,366
27,820
27,290
51,558
51,271
51,004
53,038
53,155
53,274
53,27453,15553,03851,00451,27151,55827,29027,82028,36628,9279,7329,99910,5806,4661,6481,721141,388141,496000
       Long term Debt Total 
0
0
0
0
0
0
0
4,923
4,937
4,952
4,966
24,810
24,886
0
0
0
0
0
0
0
0
0000000024,88624,8104,9664,9524,9374,9230000000
       Warrants
0
0
0
0
139,576
139,576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000139,576139,5760000
       Other Liabilities 
0
0
0
1,920
1,812
1,721
1,648
1,543
286
286
286
286
0
287
0
0
0
0
0
0
0
000000028702862862862861,5431,6481,7211,8121,920000
> Total Stockholder Equity
3,547
0
0
-89,348
-93,316
92,155
85,477
69,592
134,425
121,504
105,718
76,908
157,709
140,523
123,707
101,685
353,542
327,869
289,058
577,155
534,999
534,999577,155289,058327,869353,542101,685123,707140,523157,70976,908105,718121,504134,42569,59285,47792,155-93,316-89,348003,547
   Common Stock
0
0
0
0
0
21
21
21
27
27
28
28
44
44
44
44
54
55
55
64
64
6464555554444444442828272721212100000
   Retained Earnings -512,944-461,250-417,825-371,193-337,485-309,102-283,447-263,343-243,181-213,112-180,673-155,994-141,141-124,056-107,209-99,598-96,161-91,447000
   Capital Surplus 
0
0
0
0
2,845
2,845
192,665
193,627
275,551
277,623
286,642
290,216
400,850
0
0
0
0
0
0
0
0
00000000400,850290,216286,642277,623275,551193,627192,6652,8452,8450000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
-137,477
2,845
191,732
283,832
193,627
275,551
277,623
286,642
290,216
400,850
403,964
407,185
410,492
691,146
699,457
705,784
1,037,948
1,047,225
1,047,2251,037,948705,784699,457691,146410,492407,185403,964400,850290,216286,642277,623275,551193,627283,832191,7322,845-137,477000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-167,170
Operating Income-167,170-167,170
 
Operating Expense (+$)
Research Development126,172
Selling General Administrative40,998
Selling And Marketing Expenses0
Operating Expense167,170167,170
 
Net Interest Income (+$)
Interest Income20,714
Interest Expense-7,626
Other Finance Cost-0
Net Interest Income13,088
 
Pretax Income (+$)
Operating Income-167,170
Net Interest Income13,088
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-152,147-182,193
EBIT - interestExpense = -167,399
-152,147
-144,522
Interest Expense7,626
Earnings Before Interest and Taxes (EBIT)-159,773-144,521
Earnings Before Interest and Taxes (EBITDA)-167,170
 
After tax Income (+$)
Income Before Tax-152,147
Tax Provision-1
Net Income From Continuing Ops-152,148-152,148
Net Income-152,148
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net15,023-13,088
 

Technical Analysis of Vera Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vera Therapeutics Inc. The general trend of Vera Therapeutics Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vera Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vera Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vera Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 31.77 < 32.65 < 33.00.

The bearish price targets are: 20.37 > 18.76 > 18.53.

Know someone who trades $VERA? Share this with them.๐Ÿ‘‡

Vera Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vera Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vera Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vera Therapeutics Inc. The current macd is -0.04735167.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vera Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vera Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vera Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartVera Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vera Therapeutics Inc. The current adx is 17.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vera Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Vera Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vera Therapeutics Inc. The current sar is 29.31.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vera Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vera Therapeutics Inc. The current rsi is 50.59. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Vera Therapeutics Inc Daily Relative Strength Index (RSI) ChartVera Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vera Therapeutics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vera Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vera Therapeutics Inc Daily Stochastic Oscillator ChartVera Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vera Therapeutics Inc. The current cci is -10.60906953.

Vera Therapeutics Inc Daily Commodity Channel Index (CCI) ChartVera Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vera Therapeutics Inc. The current cmo is 2.81697743.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartVera Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vera Therapeutics Inc. The current willr is -46.65314402.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vera Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vera Therapeutics Inc Daily Williams %R ChartVera Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Vera Therapeutics Inc.

Vera Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vera Therapeutics Inc. The current atr is 1.72781207.

Vera Therapeutics Inc Daily Average True Range (ATR) ChartVera Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vera Therapeutics Inc. The current obv is 7,192,548.

Vera Therapeutics Inc Daily On-Balance Volume (OBV) ChartVera Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vera Therapeutics Inc. The current mfi is 57.08.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Vera Therapeutics Inc Daily Money Flow Index (MFI) ChartVera Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vera Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vera Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vera Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.590
Ma 20Greater thanMa 5023.661
Ma 50Greater thanMa 10022.736
Ma 100Greater thanMa 20024.950
OpenGreater thanClose23.500
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vera Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Vera Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vera Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vera Therapeutics Inc

I send you an email if I find something interesting about Vera Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vera Therapeutics Inc.

Receive notifications about Vera Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.